EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

IL ‐6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study

A Reimer-Taschenbrecker iD, M Hess, M Davidovic, A Hwang, S Hübner, M Hofsaess, S Gewert, K Eyerich iD, C Has iD

Journal of the European Academy of Dermatology and Venereology · 2025

DOI: 10.1111/jdv.19898 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2025. Verfasst von A Reimer-Taschenbrecker und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Interleukin-6, Cytokines, Epidermolysis Bullosa. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Berta-Ottenstein Programm, Deutsche Forschungsgemeinschaft, DEBRA International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic inflammation is considered a major player in the pathogenesis of epidermolysis bullosa (EB), but its pattern has only been described in small heterogeneous cohorts. There is controversy if and how systemic inflammation should be therapeutically targeted.

Methods

We examined serum proinflammatory, anti‐inflammatory, and itch related cytokines in a paediatric cohort of 29 patients with junctional and dystrophic EB. The cytokine that emerged as the most relevant was measured in a validation cohort of 42 patients during follow‐up visits over 2 years.

Results

IL‐6 showed the most consistent and highest aberration dominating systemic inflammation. IL‐6 correlated with wound body surface area (BSA) in both, finding and validation cohorts. Patients with less than 3% wound BSA had normal IL‐6, while IL‐6 levels significantly increased at more than 5% and 10% of wound BSA. TGF‐β was only marginally elevated in patients with severe recessive dystrophic EB, while TNF‐α, IFN‐γ and IL‐1β varied inconsistently. Patients reporting itch showed elevations in type 2 immunity (IgE, TSLP, IL4 and/or IL‐31, respectively).

Conclusions

Our data suggest a dominant skin barrier and wound healing inflammatory pattern in junctional and dystrophic EB that depends on the wound area and not on the EB type. In EB, itch mediators may be similar to other pruritic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6CytokinesEpidermolysis BullosaHumansProspective StudiesFemaleMaleChildChild, PreschoolAdolescentTransforming Growth Factor betaTumor Necrosis Factor-alphaInterleukinsPruritusEpidermolysis Bullosa DystrophicaInterleukin-1betaInterferon-gammaInfantInterleukin-4Severity of Illness IndexEpidermolysis Bullosa, Junctional

Substanzen

Interleukin-6CytokinesTransforming Growth Factor betaTumor Necrosis Factor-alphaInterleukinsInterleukin-1betaInterferon-gammaIL31 protein, humanInterleukin-4IL4 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.
  • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Institute of Medical Biometry and Statistics, Medical Faculty and Medical Center, University of Freiburg, Freiburg, Germany.

ORCID-Profile: A Reimer-Taschenbrecker, K Eyerich, C Has

Förderung

  • Berta-Ottenstein Programm
  • Deutsche Forschungsgemeinschaft
  • DEBRA International

Zitieren

APA

Reimer-Taschenbrecker, A., Hess, M., Davidovic, M., Hwang, A., Hübner, S., Hofsaess, M., Gewert, S., Eyerich, K., & Has, C. (2025). IL ‐6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19898

Vancouver

Reimer-Taschenbrecker A, Hess M, Davidovic M, Hwang A, Hübner S, Hofsaess M, et al. IL ‐6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study. Journal of the European Academy of Dermatology and Venereology. 2025. doi:10.1111/jdv.19898

BibTeX
@article{ReimerTaschenbrecker2025,
  author = {Reimer-Taschenbrecker, A and Hess, M and Davidovic, M and Hwang, A and Hübner, S and Hofsaess, M and Gewert, S and Eyerich, K and Has, C},
  title = {IL ‐6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  doi = {10.1111/jdv.19898}
}
Kostenlos starten →